{"transactions":[{"id":921044,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":67903,"kind":"person","name":"Daws D. Ryan","position":1,"cik":"0001598602","reported_name":"Daws D. Ryan","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T16:10:07.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service."}],"balance_after":220000,"derivative":{"exercise_price":9.53,"expiration_date":"2036-01-30","underlying":"Common Shares","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0000929638-26-000481","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598602/000092963826000481/form4.xml","form_type":"4"}},{"id":1289149,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":67903,"kind":"person","name":"Daws D. Ryan","position":1,"cik":"0001598602","reported_name":"Daws D. Ryan","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-31T16:40:20.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service."}],"balance_after":280000,"derivative":{"exercise_price":7.39,"expiration_date":"2035-01-29","underlying":"Common Shares","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0000929638-25-000478","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598602/000092963825000478/form4.xml","form_type":"4"}},{"id":1723452,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":67903,"kind":"person","name":"Daws D. Ryan","position":1,"cik":"0001598602","reported_name":"Daws D. Ryan","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-04T17:52:42.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":232000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years."}],"balance_after":232000,"derivative":{"exercise_price":7.66,"expiration_date":"2033-11-30","underlying":"Common Shares","underlying_shares":232000},"source":{"system":"sec-edgar","filing":"0000929638-23-003339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598602/000092963823003339/form4.xml","form_type":"4"}},{"id":4496025,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":67903,"kind":"person","name":"Daws D. Ryan","position":1,"cik":"0001598602","reported_name":"Daws D. Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-01-06T17:03:47.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in sixteen equal quarterly installments beginning on April 4, 2017."}],"balance_after":82500,"derivative":{"exercise_price":10.97,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-17-002680","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919117002680/doc4.xml","form_type":"4"}}]}